1. 2024
  2. Brainstem transcriptomic changes in male Wistar rats after acute stress, comparing the use of duplex specific nuclease (DSN)

    Lanshakov, D. A., Sukhareva, E. V., Bulygina, V. V., Khozyainova, A. A., Gerashchenko, T. S., Denisov, E. V. & Kalinina, T. S., Dec 2024, In: Scientific Reports. 14, 1, 25 p., 21856.

    Research output: Contribution to journalArticlepeer-review

  3. 2021
  4. Single neonatal dexamethasone administration has long-lasting outcome on depressive-like behaviour, Bdnf, Nt-3, p75ngfr and sorting receptors (SorCS1-3) stress reactive expression

    Lanshakov, D. A., Sukhareva, E. V., Bulygina, V. V., Bannova, A. V., Shaburova, E. V. & Kalinina, T. S., 14 Apr 2021, In: Scientific Reports. 11, 1, 13 p., 8092.

    Research output: Contribution to journalArticlepeer-review

  5. 2020
  6. The relationship between the noradrenergic system activity and the expression of cytokines in the neonatal rat brain

    Kalinina, T., Bulygina, V., Egorova, K., Sukhareva, E. & Dygalo, N., Nov 2020, In: European Neuropsychopharmacology. 40, p. S55-S56 2 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  7. Chemogenetic Activation of Glutamatergic Neurons in the Juvenile Rat Cortex Reduces Anxiety

    Dygalo, N. N., Lanshakov, D. A., Komysheva, N. P., Drozd, U. S., Shaburova, E. V., Sukhareva, E. V. & Shishkina, G. T., 1 Jan 2020, In: Doklady Biochemistry and Biophysics. 490, 1, p. 16-18 3 p., 5.

    Research output: Contribution to journalArticlepeer-review

  8. 2019
  9. Extrahypothalamic CRH and its receptors change tyrosine hydroxylase expression after neonatal dexamethasone treatment

    Sukhareva, E. V., Lanshakov, D., Kalinina, T., Bulygina, V. & Dygalo, N., Dec 2019, In: European Neuropsychopharmacology. 29, p. S301-S302 2 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  10. Long-term up-regulation of tyrosine hydroxylase gene expression after neonatal dexamethasone

    Kalinina, T., Sukhareva, E., Bulygina, V., Lanshakov, D., Egorova, K. & Dygalo, N., Dec 2019, In: European Neuropsychopharmacology. 29, p. S166-S167 6 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  11. Subanesthetic dose of ketamine relieves depression-like behavior induced by optogenetic stimulation of the hippocampal pyramidal neurons

    Dygalo, N., Drozd, U. S., Kalinina, T. S., Sukhareva, E. V., Bulygina, V. V., Shishkina, G. T. & Lanshakov, D. A., Dec 2019, In: European Neuropsychopharmacology. 29, p. S94-S94 1 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  12. Ketamine improves depressive symptoms caused by stress and induces c-Fos expression in the brain resembling some effects of stress

    Dygalo, N., Drozd, U. S., Kalinina, T. S., Sukhareva, E. V., Bulygina, V. V., Shishkina, G. T. & Lanshakov, D. A., 2019, In: European Neuropsychopharmacology. 29, p. S212-S212 1 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  13. TpH2 expression after neonatal dexamethasone treatment and acute or chronic stress in adulthood

    Kalinina, T., Sukhareva, E., Lanshakov, D., Bulygina, V. & Dygalo, N., 2019, In: European Neuropsychopharmacology. 29, p. S222-S222 1 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

Previous 1 2 Next

ID: 3437341